Press release
AMD Drugs Market Size, Share, Growth Analysis, and Report 2024-2031
AMD Drugs Market was valued at US$ 9,717.64 million in 2023 and is estimated to reach US$ 15,903.86 million by 2031, growing at a CAGR of 7.26% during the forecast period (2024-2031).The AMD (Age-related Macular Degeneration) drugs market refers to the sector of the pharmaceutical industry that deals with the development, production, and distribution of medications used to treat or manage Age-related Macular Degeneration. AMD is a progressive eye condition that affects the macula, the part of the retina responsible for sharp, central vision. It is a leading cause of vision loss in older adults.
Get a Free Sample Research PDF: https://www.datamintelligence.com/download-sample/amd-drugs-market
Market Dynamics:
The increasing number of novel product launches and the rising regulatory approvals will drive market growth.
The global market for age-related macular degeneration (AMD) drugs is experiencing significant growth due to several factors. The increasing geriatric population and a rise in AMD cases are major drivers. Additionally, the surge in novel product launches and ongoing clinical trials contribute to this growth.
For example, in August 2022, Kodiak Sciences Inc. reported positive outcomes from the Phase 3 BEACON study of its new antibody biopolymer conjugate, tarcocimab tedromer (KSI-301: tarcocimab). The drug achieved the primary endpoint of non-inferior visual acuity change at 24 weeks compared to aflibercept in patients with macular edema.
Further boosting the market, advancements in technology, increased funding, and regulatory approvals are fueling demand for AMD drugs. Notably, in October 2021, Genentech received FDA approval for Susvimo (ranibizumab injection), administered via an intravitreal ocular implant. This treatment is for patients with neovascular or wet AMD who have previously responded to at least two anti-vascular endothelial growth factor injections.
Segment Covered in the AMD Drugs Market:
By Product Type: Wet AMD, Dry AMD.
By Drug Type: Lucentis, Eylea, Avastin, Others.
By Route of Administration: Intravenous, Intravitreal.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/protein-labeling-market
Key players involved in AMD Drugs Market:
• Bayer HealthCare LLC
• F. Hoffmann-La Roche Ltd.
• Regeneron Pharmaceuticals, Inc.
• Novartis AG
• Pfizer Inc.
• Kubota Pharmaceutical Holdings Inc.
• AbbVie Inc.
• Kodiak Sciences
• Genentech Inc., Roche Group Member
• Regenxbio Inc.
Related Reports:
Endometriosis Drug Market: https://www.datamintelligence.com/research-report/endometriosis-drug-market
Oral Cavity Cancer Market: https://www.datamintelligence.com/research-report/oral-cavity-cancer-market
Pharmacovigilance Market: https://www.datamintelligence.com/research-report/pharmacovigilance-market
Product Portfolio:
Eylea
Eylea is an approved anti-VEGF (vascular endothelial growth factor) therapy known for its long-lasting efficacy. Clinical trials have demonstrated that Eylea can be administered with a Treat and Extend (T&E) dosing regimen, successfully extending treatment intervals up to approximately 16 weeks. This extended interval provides sustained anti-VEGF activity, making Eylea a valuable option in managing conditions associated with VEGF.
Regional Analysis:
The AMD Drugs Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The AMD Drugs Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AMD Drugs Market Size, Share, Growth Analysis, and Report 2024-2031 here
News-ID: 3649283 • Views: …
More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…

United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…

United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…

United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for AMD
Onlive Server Brings AI-Powered AMD Dedicated Servers
We are all aware of how useful, and sometimes even crucial, proper hosting services can be for a business. That is why Onlive Server is providing this new option with the newly recommended AI-powered AMD Dedicated Server Hosting[https://onliveserver.com/amd-dedicated-server-hosting/]. Furthermore, these servers are powered by AMD technology and do superbly in servicing the tremendous demand of agile business workloads with modern AI computations, big data, and other emerging technologies.
AI-powered solutions are…
Age-Related Macular Degeneration Market To Expand, Fuelled By Innovations In Dry …
The Age-related Macular Degeneration Market (AMD) is poised for significant growth over the coming years, with projections indicating a compound annual growth rate (CAGR) of 6.2%, leading to an estimated market value of $20 billion by the end of the forecast period. This robust expansion is driven by several critical factors, including the rising prevalence of eye diseases, advancements in medical technology, and an aging population that is increasingly susceptible…
AMD Workstations Market | BIZON, BOXX Technologies, Broadberry, Dell
The global amd workstations market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the amd workstations market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Airway Management Products (AMD) Market 2021 | Detailed Report
Airway Management Products (AMD) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5262437
The report provides a comprehensive analysis of company profiles listed below:
- Medtronic
- Teleflex
- Ambu
- Smiths Medical
- Intersurgical
- Becton Dickinson
- Armstrong Medical
- Medline Industries
Airway Management Products…
Age-Related Macular Degeneration (AMD) Market Report 2018: Segmentation by Type …
Global Age-Related Macular Degeneration (AMD) market research report provides company profile for F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.…
Global Microprocessor Market 2018 - Intel, Qualcomm, Apple, AMD
Apex Market Reports, recently published a detailed market research study focused on the “Microprocessor Market” across the global, regional and country level. The report provides 360° analysis of “Microprocessor Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Microprocessor on the basis of…